azcorvit capsule
surechoice pharma phils., inc. - ascorbic acid , zinc - capsule - 500mg (equivalent to 562.42 mg sodium ascorbate)/10 mg (equivalent to 27.50 mg zinc sulfate monohydrate)
none 200,000 iu softgel capsule
surechoice pharma phils., inc. - retinol (as palmitate) - softgel capsule - 200,000 iu
alici-a 200,000 iu softgel capsule
am-europharma corp; distributor: surechoice pharma phils, inc. - retinol palmitate - softgel capsule - 200,000 iu
none capsule
surechoice pharma phils., inc. - ferrous sulfate , folic acid ,vitamin b complex - capsule - [see reverse for formulation]
none 2mg/ 5ml syrup
surechoice pharma phils., inc. - salbutamol (as sulfate) - syrup - 2mg/ 5ml
none 500mg (equi. to 568.18mg of sodium ascorbate) capsule
surechoice pharma phils., inc. - ascorbic acid - capsule - 500mg (equi. to 568.18mg of sodium ascorbate)
urecholine- bethanechol chloride tablet
teva women's health, inc. - bethanechol chloride (unii: h4qbz2lo84) (bethanechol - unii:004f72p8f4) - bethanechol chloride 5 mg - bethanechol chloride tablets usp are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. hypersensitivity to bethanechol chloride, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia
aimovig solution
novartis pharmaceuticals canada inc - erenumab - solution - 70mg - erenumab 70mg - calcitonin-gene-related peptide (cgrp) antagonists
aimovig solution
novartis pharmaceuticals canada inc - erenumab - solution - 70mg - erenumab 70mg - calcitonin-gene-related peptide (cgrp) antagonists
aimovig solution
novartis pharmaceuticals canada inc - erenumab - solution - 140mg - erenumab 140mg - calcitonin-gene-related peptide (cgrp) antagonists